First Patient Treated In Adipose Stem & Regenerative Cell Study For Stress Urinary Incontinence (Medical News Today) PDF Print

Cytori (NASDAQ: CYTX) announced that the first patient was enrolled in an investigator-initiated safety and feasibility study using adipose-derived stem and regenerative cells to treat stress urinary incontinence. The 10-patient study is being conducted independently by Nagoya University Hospital in Japan.

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.